The pathogenesis of sepsis: Factors that modulate the response to gram- negative bacterial infection

Clinics in Chest Medicine

Volumn 17, Issue 2, 1996, Pages 183-197

  Marsh, C B ^a   Wewers, M D ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; FC RECEPTOR; GAMMA INTERFERON; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE B4; LIPOPOLYSACCHARIDE; NITRIC OXIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

BACTEREMIA; BACTERIAL INFECTION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HEART PERFORMANCE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; MEDIATOR RELEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEPSIS;

EID: 0029891674     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70308-7     Document Type: Article

References (203)

1. E. Abraham R. Wunderink H. Silverman Efficacy and safety of monoclonal antibody to tumor necrosis factor-α in patients with sepsis syndrome JAMA 273 1995 934 941
2. B.B. Aggarwal W.J. Kohr P.E. Hass Human tumor necrosis factor: Production, purification, and characterization J Biol Chem 260 1985 2345 2354
3. T. Akahoshi H. Endo H. Kondo Essential involvement of interleukin-8 in neutrophil recruitment in rabbits with acute experimental arthritis induced by lipopolysaccharide and interleukin-1 Lymphokine Cytokine Res 13 1994 113 116
4. H.R. Alexander G.M. Doherty C.M. Buresh A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice J Exp Med 173 1991 1029 1032
5. J.N. Allen D.J. Herzyk E.D. Allen Human whole blood interleukin-1β production: Kinetics, cell source, and comparison to TNF-α J Lab Clin Med 119 1992 538 546
6. C.L. Anderson L. Shen D.M. Eicher Phagocytosis mediated by three distinct Fcγ receptor classes on human leukocytes J Exp Med 171 1990 1333 1345
7. V.T. Andriole Urinary tract infections in the 90s: Pathogenesis and management Infection 20 suppl 4 1992 S251 S256
8. M. Arditi J. Zhou R. Dorio Endotoxin-mediated endothelial cell injury and activation: Role of soluble CD14 Infect Immun 61 1993 3149 3156
9. W.P. Arend Interleukin 1 receptor antagonist: A new member of the interleukin 1 family J Clin Invest 88 1991 1445 1451
10. W.P. Arend F.G. Joslin R.C. Thompson An IL-1 inhibitor from human monocytes: Production and characterization of biologic properties J Immunol 143 1989 1851 1858
11. W.P. Arend M.F. Smith R.W. Janson IL-1 receptor antagonist and IL-1 β production in human monocytes are regulated differently J Immunol 147 1991 1530 1536
12. P.E. Auron S.J.C. Warner A.C. Webb Studies on the molecular nature of human interleukin 1 J Immunol 138 1987 1447 1456
13. M. Baggiolini B. Dewald B. Moser Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines Adv Immunol 55 1994 97 179
14. D.W. Banner A. D'Arcy W. Janes Crystal structure of the soluble human 55 kDTNF receptor-human TNF-β complex: Implications for TNF receptor activation Cell 73 1993 431 445
15. R.A. Barthelson F.H. Valone Platelet-activating factor stimulates expression of IL-1β mRNA in THP-1 cells Lipids 26 1991 257 260
16. D. Beasley M. Eldridge Interleukin-1β and tumor necrosis factor-α synergistically induce NO synthase in rat vascular smooth muscle cells Am J Physiol 266 pt 2 1994 R1197 R1203
17. K. Bendtzen T. Mandrup-Poulsen J. Nerup Cytotoxicity of human pl 7 interleukin-1 for pancreatic islets of Langerhans Science 1986 1545 1547
18. A.E. Berger D.B. Carter S.O. Hankey Cytokine regulation of the interleukin-1 receptor antagonist protein in U937 cells Eur J Immunol 23 1993 39 45
19. B. Beutler A. Cerami Cachectin and tumor necrosis factor as two sides of the same biological coin Nature 320 1986 584 588
20. B. Beutler A. Cerami Cachectin: More than a tumor necrosis factor N Engl J Med 316 1987 379 385
21. B. Beutler I.W. Milsark A.C. Cerami Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science 229 1985 869 871
22. J. Bigda I. Beletsky C. Brakebusch Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity J Exp Med 180 1994 445 460
23. R.A. Black S.R. Kronheim P.R. Sleath Activation of interleukin-1β by a co-induced protease FEBS Lett 247 1989 386 390
24. R.A. Black S.R. Kronheim M. Cantrell Generation of biologically active interleukin-1β by proteolytic cleavage of the inactive precursor J Biol Chem 263 1988 9437 9442
25. R.C. Bone Gram-negative sepsis: Background, clinical features, and intervention Chest 100 1991 802 808
26. R.C. Bone The pathogenesis of sepsis [review] Ann Intern Med 115 1991 457 469
27. D. Boraschi L. Villa P. Ghiara Mechanism of acute toxicity of IL-1β in mice Eur Cytokine Netw 2 1991 61 67
28. E.C. Borden P. Chin Interleukin-6: A cytokine with potential diagnostic and therapeutic roles [review] J Lab Clin Med 123 1994 824 829
29. D. Burger R. Chichportice J.G. Giri The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor J Clin Invest 96 1995 38 41
30. R. Burrell Human responses to bacterial endotoxin [review] Circ Shock 43 1994 137 153
31. G. Camussi F. Mariano L. Biancone Lipopolysaccharide-binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide J Immunol 155 1995 316 324
32. J.G. Cannon R.G. Tompkins J.A. Gelfand Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever J Infect Dis 161 1990 79 84
33. B.D. Car V.M. Eng B. Schnyder Interferon-γ receptor deficient mice are resistant to endotoxic shock J Exp Med 179 1994 1437 1444
34. D.B. Carter M.R. Deibel Jr C.J. Dunn Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein Nature 344 1990 633 638
35. L.C. Casey R.A. Balk R.C. Bone Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome Ann Intern Med 119 1993 771 778
36. M.A. Cassatella L. Meda S. Bonora Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide J Exp Med 178 1993 2207 2211
37. J.V. Castell M.J. Gomez-Lechon M. David Interleukin-6 is the major regulator of acute-phase protein synthesis in adult human hepatocytes FEBS Lett 242 1989 237 239
38. Centers for Disease Control Increase in national hospital discharge rates for septicemia—United States MMWR 39 1990 31 34
39. D.P. Cerretti C.J. Kozlosky B. Mosley Molecular cloning of the interleukin-1β converting enzyme Science 256 1992 97 100
40. T.W. Chang M.H. Wu Y.J. Yang Blood levels of platelet-activating factor in endotoxin-sensitive and endotoxin-resistant mice during endotoxemia J Formos Med Assoc 91 1992 1133 1137
41. A.E. Chernoff E.V. Granowitz L. Shapiro A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses J Immunol 154 1995 5492 5499
42. F. Colotta F. Re M. Muzio Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4 Science 261 1993 472 475
43. A.F. Coughlan H. Hau L.C. Dunlop P-selectin and platelet-activating factor mediate initial endotoxin-induced neutropenia J Exp Med 179 1994 329 334
44. F.Q. Cunha S. Moncada F.Y. Liew Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages Biochem Biophys Res Commun 182 1992 1155 1159
45. F.Q. Cunha J. Assreuy D.W. Moss Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: Role of TNF-α and IL-1β Immunology 81 1994 211 215
46. M.I. Cybulsky M.K.W. Chan H.Z. Movat Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection Lab Invest 58 1988 365 378
47. P. Damas A. Reuter P. Gysen Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans Crit Care Med 17 1989 975 978
48. W.C. Darbonne G.C. Rice M.A. Mohler Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin J Clin Invest 88 1991 1362 1369
49. J.-M. Dayer B. Beutler A. Cerami Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin-E2 production by human synovial cells and dermal fibroblasts J Exp Med 162 1985 2163 2168
50. J.P. de Boer A.A. Creasey A. Chang Activation of the complement system in baboons challenged with live Escherichia coli: Correlation with mortality and evidence for a biphasic activation pattern Infect Immun 61 1993 4293 4301
51. E.A. Deitch Bacterial translocation: The influence of dietary variables Gut 35 suppl 1994 S23 S27
52. B. Derkz A. Marchant M. Goldman High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock J Infect Dis 171 1995 229 232
53. J.F. Dhainaut A. Tenaillon Y. Le Tulzo Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group Crit Care Med 22 1994 1720 1728
54. C.A. Dinarello Interleukin-1 and interleukin-1 antagonism Blood 77 1991 1627 1652
55. C.A. Dinarello Interleukin-1 and the pathogenesis of the acute-phase response N Engl J Med 311 1984 1413 1418
56. C.A. Dinarello The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome J Infect Dis 163 1991 1177 1184
57. C.A. Dinarello J.G. Cannon S.M. Wolff Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1 J Exp Med 163 1986 1433 1450
58. A. Dobrina B.R. Schwartz T.M. Carlos CD11/CD18-independent neutrophil adherence to inducible endothelial-leucocyte adhesion molecules (ELAM) in vitro Immunology 67 1989 502 508
59. W.F. Doe S.T. Yang D.C. Morrison Macrophage stimulation by bacterial lipopolysaccharides: II. Evidence for differentiation signals delivered by lipid A and by a protein-rich fraction of lipopolysaccharides J Exp Med 148 1978 557 568
60. D.E. Doherty L. Zagarella P.M. Henson Lipopolysaccharide stimulates monocyte adherence by effects on both the monocyte and the endothelial cell J Immunol 143 1989 3673 3679
61. D.J. Dripps B.J. Brandhuber R.C. Thompson Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction J Biol Chem 266 1991 10331 10336
62. J.-J. Durieux N. Vita O. Popescu The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes Eur J Immunol 24 1994 2006 2012
63. S.P. Eisenberg M.T. Brewer E. Verderber Interleukin-1 receptor antagonist is a member of the interleukin-1 gene family: Evolution of a cytokine control mechanism Proc Natl Acad Sci USA 88 1991 5232 5236
64. S.P. Eisenberg R.J. Evans W.P. Arend Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist Nature 343 1990 341 346
65. J.A. Elias V. Lentz IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA J Immunol 145 1990 161 166
66. J.J. Enghild I.B. Thogersen G. Salvesen α-Macroglobulin from Limulus polyphemus exhibits proteinase inhibitory activity and participates in a hemolytic system Biochemistry 29 1990 10 070-10,080
67. S.L. Erickson F.J. de Sauvage K. Kikly Decreased sensitivity to tumour necrosis factor but normal T-cell development in TNF receptor-2—deficient mice Nature 372 1994 560 563
68. W. Ertel M.H. Morrison P. Wang The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukins Ann Surg 214 1991 141 148
69. T. Evans A. Carpenter A. Silva Inhibition of nitric oxide synthase in experimental gram-negative sepsis J Infect Dis 169 1994 343 349
70. T.J. Evans A. Carpenter D. Moyes Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis J Infect Dis 171 1995 153 160
71. T.C. Fabian M.A. Croce R.M. Stewart Neutrophil CD18 expression and blockade after traumatic shock and endotoxin challenge Ann Surg 220 1994 552 561
72. L.S. Feder D.L. Laskin Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1β following acute endotoxemia J Leukoc Biol 55 1994 507 513
73. B.A. Feltis R.P. Jechorek S.L. Erlandsen Bacterial translocation and lipopolysaccharide-induced mortality in genetically macrophage-deficient op/op mice Shock 2 1994 29 33
74. E. Ferrero D. Jiao B.Z. Tsuberi Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide Proc Natl Acad Sci USA 90 1993 2380 2384
75. C.J. Fisher Jr J.-F.A. Dhainaut S.M. Opal Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trial JAMA 271 1994 1836 1843
76. E. Fischer M.A. Marano K.J. Van Zee Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia J Clin Invest 89 1992 1551 1557
77. E. Fischer K.J. Van Zee M.A. Marano Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease Blood 79 1992 2196 2200
78. Y. Fong K.J. Tracey L.L. Moldawer Antibodies to cachectin/tumor necrosis factor reduce interleukin-1β and interleukin 6 appearance during lethal bacteremia J Exp Med 170 1989 1627 1633
79. B. Fouqueray V. Boutard C. Philippe Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide Am J Pathol 147 1995 176 182
80. M.M. Frank Complement in the pathophysiology of human disease N Engl J Med 316 1987 1525 1530
81. K. Fukatsu H. Saito R. Fukushima Detrimental effects of a nitric oxide synthase inhibitor (N-omeganitro-L-arginine-methyl-ester) in a murine sepsis model Arch Surg 130 1995 410 414
82. H. Gazzano-Santoro K. Meszaros C. Birr Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria Infect Immun 62 1994 1185 1191
83. C. Gerard C. Bruyns A. Marchant Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia J Exp Med 177 1993 547 550
84. J.E. Gershenwald Y. Fong T.J. Fahey III Interleukin-1 receptor blockade attenuates the host inflammatory response Proc Natl Acad Sci USA 87 1990 4966 4970
85. P. Ghezzi C.A. Dinarello IL-1 induces IL-1: III. Specific inhibition of IL-1 production by IFN-γ J Immunol 140 1988 4238 4244
86. J.G. Giri J. Wells S.K. Dower Elevated levels of the shed type II IL-1 receptor in sepsis: Potential role for type II receptor in regulation of IL-1 responses J Immunol 153 1994 5802 5809
87. L.L. Go P.J. Healey S.C. Watkins The effect of endotoxin on intestinal mucosal permeability to bacteria in vitro Arch Surg 130 1995 53 58
88. D.T. Golenbock R.R. Bach H. Lichenstein Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells J Lab Clin Med 125 1995 662 671
89. J. Gomez-Jimenez M.C. Martin R. Sauri Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock J Infect Dis 171 1995 472 475
90. R.M. Graham M.E. Strahan K.W. Norman Platelet and plasma platelet-activating factor in sepsis and myocardial infarction Journal of Lipid Mediators & Cell Signalling 9 1994 167 182
91. E.V. Granowitz B.D. Clark E. Vannier Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes Blood 79 1992 2356 2363
92. E.V. Granowitz A.A. Santos D.D. Poutsiaka Production of interleukin-1-receptor antagonist during experimental endotoxaemia Lancet 338 1991 1423 1424
93. E.V. Granowitz E. Vannier D.D. Poutsiaka Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes Blood 79 1992 2364 2369
94. C.H. Hannum C.J. Wilcox W.P. Arend Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor Nature 343 1990 336 340
95. P.H. Hart G.A. Whitty D.S. Piccoli Synergistic activation of human monocytes by granulocyte-macrophage colony-stimulating factor and INF-γ: Increased TNF-α but not IL-1 activity J Immunol 141 1988 1516 1521
96. A. Haziot S. Chen E. Ferrero The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage J Immunol 141 1988 547 552
97. D. Hazuda R.L. Webb P. Simon Purification and characterization of human recombinant precursor interleukin-1β J Biol Chem 264 1989 1689 1692
98. L. Hempel D. Korholz H. Bonig Interleukin-10 directly inhibits the interleukin-6 production in T-cells Scand J Immunol 41 1995 462 466
99. W.R. Henderson The role of leukotrienes in inflammation Ann Intern Med 121 1994 684 697
100. B.E. Henricson R. Neta S.N. Vogel An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance Infect Immun 59 1991 1188 1191
101. H. Heremans C. Dillen J. Van Damme Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice Eur J Immunol 24 1994 1155 1160
102. D. Heumann P. Gallay C. Barras Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes J Immunol 148 1992 3505 3512
103. S.M. Hollenberg R.E. Cunnion J. Zimmerberg Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats Am J Physiol 264 pt 2 1993 H660 H663
104. M. Howard T. Muchamuel S. Andrade Interleukin-10 protects mice from lethal endotoxemia J Exp Med 177 1993 1205 1208
105. G.E. Jarvis R.J. Evans Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro Res Vet Sci 57 1994 317 324
106. M. Kawamura Z. Terashita Y. Imura Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: Possible role of PAF in tissue factor generation Thromb Res 70 1993 281 293
107. J. Kohler D. Heumann G. Garotta IFN-γ involvement in the severity of gram-negative infections in mice J Immunol 151 1993 916 921
108. M. Kopf H. Baumann G. Freer Impaired immune and acute-phase responses in interleukin-6-deficient mice Nature 368 1994 339 342
109. S. Lamas T. Michel B.M. Brenner Nitric oxide synthesis in endothelial cells: Evidence for a pathway inducible by TNF-α Am J Physiol 261 pt 1 1991 C634 C641
110. P.J. Lehner K.A. Davies M.J. Walport Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide release Lancet 340 1992 1379 1381
111. P. Li H. Allen S. Banerjee Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock Cell 80 1995 401 411
112. C. Libert N. Takahashi A. Cauwels Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality Eur J Immunol 24 1994 2237 2242
113. J.A. Lorente L. Landin E. Renes Role of nitric oxide in the hemodynamic changes of sepsis Crit Care Med 21 1993 759 767
114. F. Lund-Johansen J. Olweus Aarli Å.A. Signal transduction in human monocytes and granulocytes through the PI-linked antigen CD14 FEBS Lett 273 1990 55 58
115. J. Mancilla P. Garcia C.A. Dinarello IL-1 receptor antagonist can either protect or enhance the lethality of Klebsiella pneumoniae sepsis in the newborn rat Infect Immun 61 1993 926 932
116. A. Marchant C. Bruyns P. Vandenabeele Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia Eur J Immunol 24 1994 1167 1171
117. A. Marchant C. Bruyns P. Vandenabeele The protective role of interleukin-10 in endotoxin shock Prog Clin Biol Res 388 1994 417 423
118. J.D. Marks C.B. Marks J.M. Luce Plasma tumor necrosis factor in patients with septic shock: Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration Am Rev Respir Dis 141 1990 94 97
119. M.N. Marra C.G. Wilde M.S. Collins The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin J Immunol 148 1992 532 537
120. C.B. Marsh M.D. Wewers Cytokine induced interleukin-1 receptor antagonist release in mononuclear phagocytes Am J Respir Cell Mol Biol 10 1994 521 525
121. C.B. Marsh H.A. Pope M.D. Wewers Fcγ cross-linking downregulates IL-1ra and induces IL-1B in mononuclear phagocytes stimulated with endotoxin or Staphylococcus aureus J Immunol 152 1994 4604 4611
122. C.B. Marsh J.E. Gadek G.C. Kindt Monocyte Fcγ receptor cross-linking induces IL-8 production J Immunol 155 1995 3161 3167
123. C.B. Marsh S.A. Moore H.A. Pope Interleukin-1 receptor antagonist suppresses endotoxin induced interleukin-1β and tumor necrosis factor-α release from mononuclear phagocytes Am J Physiol Lung Cell Mol Physiol 267 1994 L39 L45
124. G.D. Martich R.L. Danner M. Ceska Detection of interleukin-8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of antiinflammatory agents J Exp Med 173 1991 1021 1024
125. C. Marty B. Misset F. Tamion Circulating interleukin-8 concentrations in patients with multiple organ failure or septic and non-septic origin Crit Care Med 22 1994 673 679
126. J.C. Mathison E. Wolfson R.J. Ulevitch Participation of tumor necrosis factor in the mediation of gram-negative bacterial lipopolysaccharide-induced injury in rabbits J Clin Invest 81 1988 1925 1937
127. K.W. McIntyre G.J. Stepan K.D. Kolinsky Inhibition of interleukin-1 (IL- 1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody J Exp Med 173 1991 931 939
128. M.J. McNamara J.A. Norton R.J. Nauta Interleukin-1 receptor antibody (IL-1ab) protection and treatment against lethal endotoxemia in mice J Surg Res 54 1993 316 321
129. H.R. Michie K.R. Manogue D.R. Spriggs Detection of circulating tumor necrosis factor after endotoxin administration N Engl J Med 318 1988 1481 1486
130. R.H. Miles T.P. Paxton D.J. Dries Interferon-γ increases mortality following cecal ligation and puncture J Trauma 36 1994 607 611
131. K.M. Mohler D.S. Torrance C.A. Smith Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists J Immunol 151 1993 1548 1561
132. M. Morin R. Schindler G. Wakabayashi Picogram concentrations of endotoxin stimulate synthesis of IL-1β and TNF-α by human peripheral blood mononuclear cells exposed to recombinant human C5a Eur Cytokine Netw 2 1991 27 30
133. M.S. Mulligan M.L. Jones M.A. Bolanowski Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody J Immunol 150 1993 5585 5595
134. R.S. Munford C.L. Hall Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme Science 234 1986 203 205
135. H.W. Murray Interferon-γ, the activated macrophage, and host defense against microbial challenge Ann Intern Med 108 1988 595 608
136. P.R. Myers J.L. Parker M.A. Tanner Effects of cytokines tumor necrosis factor-α and interleukin 1β on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production in vascular endothelium Shock 1 1994 73 78
137. H. Nakae S. Endo K. Inada Relationship between cytokines and leukotriene B4 in sepsis Res Commun Chem Pathol Pharmacol 83 1994 151 156
138. A. Nakane T. Minagawa K. Kato Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection Infect Immun 56 1988 2563 2569
139. C. Natanson P.W. Eichenholz R.L. Danner Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock J Exp Med 169 1989 823 832
140. C. Natanson W.D. Hoffman A.F. Suffredini Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis Ann Intern Med 120 1994 771 783
141. P.P. Nawroth I. Bank D. Handley Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1 J Exp Med 163 1986 1363 1375
142. M. Niehorster G. Tiegs U.F. Schade In vivo evidence for protease-catalyzed mechanism providing bioactive TNF-α Biochem Pharmacol 40 1990 1601 1603
143. H. Niiro T. Otsuka S. Kuga IL-10 inhibits prostaglandin-E2 production by lipopolysaccharidestimulated monocytes Int Immunol 6 1994 661 664
144. H. Northoff D. Gluck A. Wolpl Lipopolysaccharide-induced elaboration of interleukin-1 by human monocytes: Use for detection of lipopolysaccharide in serum and the influence of serum-lipopolysaccharide interactions Rev Infect Dis 9 1987 S599 S601
145. M.G. O'Sullivan F.H. Chilton J.E.M. Huggins Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase J Biol Chem 267 1992 14547 14550
146. K. Ohlsson P. Björk M. Bergenfeldt Interleukin-1 receptor antagonist reduces mortality from endotoxin shock Nature 348 1990 550 552
147. S. Oksusawa J.A. Gelfand T. Ikejima Interleukin-1 induces a shock-like state in rabbits: Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition J Clin Invest 81 1988 1162 1172
148. J.E. Parillo M.M. Parker C. Natanson Septic shock in humans Ann Intern Med 113 1990 227 242
149. D. Pennica G.E. Nedwin J.S. Hayflick Human tumour necrosis factor: Precursor structure, expression and homology to lymphotoxin Nature 312 1984 724 729
150. P.Y. Perera T.Y. Chen D.C. Morrison Detection and analysis of the 80-kd lipopolysaccharide receptor in macrophages derived from L ps n and L ps d mice J Leukocyte Biol 51 1992 501 506
151. A. Petros G. Lamb A. Leone Effects of a nitric oxide synthase inhibitor in humans with septic shock Cardiovasc Res 28 1994 34 39
152. K. Pfeffer T. Matsuyama T. Kundig Mice deficient for the 55-kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection Cell 73 1993 457 497
153. J. Pugin R.J. Ulevitch P.S. Tobias A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation J Exp Med 178 1993 2193 2200
154. C.R.H. Raetz R.J. Ulevitch S.D. Wright Gramnegative endotoxin: An extraordinary lipid with profound effects on eukaryotic signal transduction FASEB J 5 1991 2652 2660
155. P. Ralph I. Nakoinz A. Sampson-Johannes IL-10, T-lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor J Immunol 148 1992 808 814
156. 4 and neutrophil attractant/activation protein (interleukin-8) sequentially in response to stimulation with lipopolysaccharide and zymosan J Clin Invest 86 1990 1556 1564
157. P. Rathanaswami M. Hachicha W.L. Wong Synergistic effect of interleukin-1β and tumor necrosis factor-α on interleukin-8 gene expression in synovial fibroblasts. Evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation Arthritis Rheum 36 1993 1295 1304
158. M.A. Rogy T. Auffenberg N.J. Espat Human tumor necrosis factor receptor (p55) and interleukin-10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses J Exp Med 181 1995 2289 2294
159. E. Ruoslahti Integrins J Clin Invest 87 1991 1 5
160. W.M. Scheld G.L. Mandell Nosocomial pneumonia: Pathogenesis and recent advances in diagnosis and therapy [review] Rev Infect Dis 13 suppl 9 1991 S743 S751
161. J. Schilling M. Cakmakci U. Battig A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase Intensive Care Med 19 1993 227 231
162. R. Schindler J.A. Gelfand C.A. Dinarello Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: Translational signal provided by lipopolysaccharide or IL-1 itself Blood 76 1990 1631 1638
163. J. Schletter H. Brade L. Brade Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein Infect Immun 63 1995 2576 2580
164. R. Schulz D.L. Panas R. Catena The role of nitric oxide in cardiac depression induced by interleukin-1β and tumour necrosis factor-α Br J Pharmacol 114 1995 27 34
165. R.R. Schumann S.R. Leong G.W. Flaggs Structure and function of lipopolysaccharide binding protein Science 249 1990 1429 1431
166. D.L. Simmons S. Tan D.G. Tenen Monocyte antigen CD14 is a phospholipid anchored membrane protein Blood 73 1989 284 289
167. W.S. Simonet T.M. Hughes T.M. Nguyen Longterm impaired neutrophil migration in mice overexpressing human interleukin-8 J Clin Invest 94 1994 1310 1319
168. J.W. Smith W.J. Urba B.D. Curti The toxic and hematologic effects of interleukin-1α administered in a phase I trial of patients with advanced hematologic malignancies J Clin Oncol 10 1992 1140 1152
169. St. John R.C. Mizer L.A. Kindt G.C. Acid aspiration-induced acute lung injury causes leukocyte-dependent systemic organ injury J Appl Physiol 74 1993 1994 2003
170. R.M. Strieter A.E. Koch V.B. Antony The immunopathology of chemotactic cytokines: The role of interleukin-8 and monocyte chemoattractant protein-1 J Lab Clin Med 123 1994 183 197
171. R.M. Strieter S.L. Kunkel H.J. Showell Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β Science 243 1989 1467 1469
172. E. Stylianou L.A.J. O'Neill L. Rawlinson Interleukin-1 induces NF-kB through its type I but not its type II receptor in lymphocytes J Biol Chem 267 1992 15836 15841
173. X. Sun M.S. Caplan W. Hsueh Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase-A2 in mice. Role of endogenous platelet-activating factor and effect of exogenous platelet-activating factor Gut 35 1994 215 219
174. X.M. Sun W. Hsueh Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice J Immunol 147 1991 509 514
175. D.L. Sylvestre J.V. Ravetch Fc receptors initiate the Arthus reaction: Redefining the inflammatory cascade Science 265 1994 1095 1098
176. C. Szabo C.C. Wu J.A. Mitchell Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide Circ Res 73 1993 991 999
177. T. Takakuwa S. Endo H. Nakae PAF acetylhydrolase and arachidonic acid metabolite levels in patients with sepsis Res Comm Chem Pathol Pharmacol 84 1994 283 290
178. A.M. Taveira H.C. Kaulbach F.S. Chuidan Brief report: Shock and multiple organ dysfunction after self-administration of salmonella endotoxin N Engl J Med 328 1993 1457 1460
179. N.A. Thornberry H.G. Bull J.R. Calaycay A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes Nature 356 1992 768 774
180. G. Tiao J. Rafferty C. Ogle Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6 Surgery 116 1994 332 337
181. P.S. Tobias K. Soldau R.J. Ulevitch Isolation of a lipopolysaccharide-binding acute-phase reactant from rabbit serum J Exp Med 164 1986 777 793
182. P.S. Tobias K.P.W.J. McAdam K. Soldau Control of lipopolysaccharide-high-density lipoprotein interactions by an acute-phase reactant in human serum Infect Immun 50 1985 73 76
183. K.J. Tracey A. Cerami Tumor necrosis factor: An updated review of its biology Crit Care Med 21 1993 S415 S422
184. K.J. Tracey B. Beutler S.F. Lowry Shock and tissue injury induced by recombinant human cachectin Science 234 1986 470 474
185. K.J. Tracey Y. Fong D.G. Hesse Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 330 1987 662 664
186. R.G. Turnbull J.A. Talbot S.M. Hamilton Hemodynamic changes and gut barrier function in sequential hemorrhagic and endotoxic shock J Trauma 38 1995 705 712
187. D. Ungureanu-Longrois J.L. Balligand R.A. Kelly Myocardial contractile dysfunction in the systemic inflammatory response syndrome: Role of a cytokine-inducible nitric oxide synthase in cardiac myocytes J Mol Cell Cardiol 27 1995 155 167
188. J.G.J. Van de Winkel C.L. Anderson Biology of human immunoglobulin G Fc receptors J Leukoc Biol 49 1991 511 524
189. T. van der Poll H.R. Buller H. ten Cate Activation of coagulation after administration of tumor necrosis factor to normal subjects N Engl J Med 322 1990 1622 1627
190. A.L. Van Dervort L. Yan P.J. Madara Nitric oxide regulates endotoxin-induced TNF-α production by human neutrophils J Immunol 152 1994 4102 4109
191. A. Waage P. Brandtzaeg T. Espevik Current understanding of the pathogenesis of gram-negative shock [review] Infect Dis Clin North Am 5 1991 781 791
192. A. Waage P. Brandtzaeg A. Halstensen The complex pattern of cytokines in serum from patients with meningococcal septic shock J Exp Med 169 1989 333 338
193. G. Wakabayashi J.A. Gelfand J.F. Burke A specific receptor antagonist for interleukin-1 prevents Escherichia coli -induced shock in rabbits FASEB J 5 1991 338 343
194. H.S. Warren M.L. Glennon N. Wainwright Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor Infect Immun 60 1992 2506 2513
195. J. Weiss P. Elsbach C. Shu Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria J Clin Invest 90 1992 1122 1130
196. M.D. Wewers J.J. Rinehart Z.-W. She Tumor necrosis factor infusions in humans prime neutrophils for hypochlorous acid production Am J Physiol Lung Cell Mol Physiol 259 1990 L276 L282
197. C.G. Wilde J.J. Seilhamer M. McGrogan Bactericidal/permeability-increasing protein and lipopolysaccharide (LPS)-binding protein. LPS binding properties and effects on LPS-mediated cell activation J Biol Chem 269 1994 17411 17416
198. S.D. Wright R.A. Ramos M. Patel Septin: A factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes J Exp Med 176 1992 719 727
199. S.D. Wright R.A. Ramos P.S. Tobias CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 249 1990 1431 1433
200. M.M. Wurfel S.T. Kunitake H. Lichenstein Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS J Exp Med 180 1994 1025 1035
201. H. Xu J.A. Gonzalo Y. St Pierre Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice J Exp Med 180 1994 95 109
202. K. Ye K.C. Koch B.D. Clark Interleukin-1 downregulates gene and surface expression of interleukin-1 receptor type I by destabilizing its mRNA, whereas interleukin-2 increases its expression Immunology 75 1992 427 434
203. E.J. Ziegler C.J. Fisher C.L. Sprung Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin: A randomized, double-blind, placebo-controlled trial N Engl J Med 324 1991 429 436